Ketamine, an Old–New Drug: Uses and Abuses
Pharmaceuticals · 21.12.2023 · 17 (1) · 16
DOI: 10.3390/ph17010016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 21.12.2023. Verfasst von Katarina Savić Vujović und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11129 Belgrade, Serbia. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ketamine as an old–new drug has a variety of clinical implications. In the last 30 years, ketamine has become popular for acute use in humans. Ketamine in standard doses is principally utilized for the induction and maintenance of surgical procedures. Besides its use in anesthesia and analgesia, recent studies have shown that ketamine has found a place in the treatment of asthma, epilepsy, depression, bipolar affective disorders, alcohol and heroin addiction. Ketamine primarily functions as a noncompetitive antagonist targeting the N-methyl-D-aspartate (NMDA) receptor, but its mechanism of action is complex. It is generally regarded as safe, with low doses and short-term use typically not leading to significant adverse effects. Also, ketamine is known as a powerful psychostimulant. During the past decade, ketamine has been one of the commonly abused drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11129 Belgrade, Serbia.
- Clinic for Otorhinolaryngology and Maxillofacial Surgery, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia.
- Hospital for ENT, KBC "Dragiša Mišović", 11000 Belgrade, Serbia.
- Clinical Centre of Montenegro, Centre for Abdominal Surgery, 81000 Podgorica, Montenegro.
- Clinical Centre of Serbia, Clinic for Psychiatry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Ana Jotić, Branislava Medić, Dragana Srebro
Zitieren
APA
Savić Vujović, K., Jotić, A., Medić, B., Srebro, D., Vujović, A., Žujović, J., Opanković, A., & Vučković, S. (2023). Ketamine, an Old–New Drug: Uses and Abuses. Pharmaceuticals, 17(1), 16. https://doi.org/10.3390/ph17010016
Vancouver
Savić Vujović K, Jotić A, Medić B, Srebro D, Vujović A, Žujović J, et al. Ketamine, an Old–New Drug: Uses and Abuses. Pharmaceuticals. 2023;17(1):16. doi:10.3390/ph17010016
BibTeX
@article{SaviVujovi2023,
author = {Savić Vujović, Katarina and Jotić, Ana and Medić, Branislava and Srebro, Dragana and Vujović, Aleksandar and Žujović, Janko and Opanković, Ana and Vučković, Sonja},
title = {Ketamine, an Old–New Drug: Uses and Abuses},
journal = {Pharmaceuticals},
year = {2023},
volume = {17},
number = {1},
pages = {16},
doi = {10.3390/ph17010016}
}
EUVIMED